Publikationen

Adler O, Zait Y, Cohen N, Blazquez R, Doron H, Monteran L, Scharff Y, Shami T, Mundhe D, Glehr G, Kanner A A, Horn S, Yahalom V, Haferkamp S, Hutchinson J A, Bleckmann A, Nahary L, Benhar I, Yust Katz S, Pukrop T, and Erez N. (2023). Reciprocal interactions between innate immune cells and astrocytes facilitate neuroinflammation and brain metastasis via lipocalin-2. Nature Cancer 4: 401-418. doi: 10.1038/s43018-023-00519-w

Agudo, J., Aguirre-Ghiso, J.A., Bhatia, M., Chodosh, L.A., Correia, A.L. & Klein, C.A.. Targeting cancer cell dormancy. Nat Rev Cancer 24, 97–104 (2024). https://doi.org/10.1038/s41568-023-00642-x

Amon L, Dudziak D, Backer RA, Clausen BE, Gmeiner C, Heger L, Jacobi L, Lehmann CHK, Probst HC, Seichter A, Tchitashvili G, Tochoedo NR, Trapaidze L, Vurnek D. 2022. Guidelines for DC preparation and flow cytometry analysis of mouse lymphohematopoietic tissues. Eur J Immunol n/a. https://doi.org/10.1002/eji.202249893

Angeloni M, Rizzi D, Schoen S, Caputo A, Merolla F, Hartmann A, Ferrazzi F*, Fraggetta F*. Closing the gap in the clinical adoption of computational pathology: a standardized, open-source framework to integrate deep-learning algorithms into the laboratory information system. bioRxiv 2024.07.11.603091; doi: https://doi.org/10.1101/2024.07.11.603091 (*: shared last authorship)

Angeloni M, van Doeveren T, Lindner S, Volland P, Schmelmer J, Foersch S, Matek C, Stoehr R, Geppert CI, Heers H, Wach S, Taubert H, Sikic D, Wullich B, van Leenders GJ, Zaburdaev V, Eckstein M, Hartmann A, Boormans JL, Ferrazzi F*, Bahlinger V*. A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing. J Pathol Clin Res. 2024 Mar;10(2):e12369. doi: 10.1002/2056-4538.12369. (*: shared last authorship)

Baasch, S., Giansanti, P., Kolter, J., Riedl, A., Forde, A. J., Runge, S., Zenke, S., Elling, R., Halenius, A., Brabletz, S., Hengel, H., Kuster, B., Brabletz, T., Cicin-Sain, L., Arens, R., Vlachos, A., Rohr, J. C., Stemmler, M. P., Kopf, M., Ruzsics, Z., … Henneke, P. (2021). Cytomegalovirus subverts macrophage identity. Cell, 184(14), 3774–3793.e25. https://doi.org/10.1016/j.cell.2021.05.009

Bäuerle, T., Gupta, S., Zheng, S., Seyler, L., Leporati, A., Marosfoi, M., Maschauer, S., Prante, O., Caravan, P., & Bogdanov, A., Jr (2021). Multimodal Bone Metastasis-associated Epidermal Growth Factor Receptor Imaging in an Orthotopic Rat Model. Radiology. Imaging cancer, 3(4), e200069. https://doi.org/10.1148/rycan.2021200069

Bénard A, Mittelstädt A, Klösch B, Glanz K, Müller J, Schoen J, Nüse B, Brunner M, Naschberger E, Stürzl M, Mattner J, Muñoz LE, Sohn K, Grützmann R, Weber GF. IL-3 orchestrates ulcerative colitis pathogenesis by controlling the development and the recruitment of splenic reservoir neutrophils. Cell Rep. 2023 Jun 8;42(6):112637. doi: 10.1016/j.celrep.2023.112637

Bittner S, Hehlgans T, and Feuerer M. (2023). Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond. Trends Immunol 44: 468-483. doi: 10.1016/j.it.2023.04.005

Blazquez R, Chuang H-N, Wenske B, Trigueros L, Wlochowitz D, Liguori R, Ferrazzi F, Regen T, Proescholdt M A, Rohde V, Riemenschneider M J, Stadelmann C, Bleckmann A, Beißbarth T, van Rossum D, Hanisch U K, and Pukrop T (2022a). Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain. Oncogene 41: 5008-5019. doi: 10.1038/s41388-022-02496-3

Blazquez R, Proescholdt M A, Klauser M, Schebesch K-M, Doenitz C, Heudobler D, Stange L, Riemenschneider M J, Bumes E, Rosengarth K, Schicho A, Schmidt N-O, Brawanski A, Pukrop T, and Wendl C. (2022b). Breakouts—A Radiological Sign of Poor Prognosis in Patients With Brain Metastases. Frontiers in Oncology 12. doi: 10.3389/fonc.2022.849880

Blazquez R, Sparrer D, Sonbol J, Philipp J, Schmieder F, and Pukrop T (2024). Organotypic 3D Ex Vivo Co-culture Model of the Macro-metastasis/Organ Parenchyma Interface. In 3D Cell Culture: Methods and Protocols, Z. Sumbalova Koledova, ed. (New York, NY: Springer US), pp. 165-176. doi: 10.1007/978-1-0716-3674-9_12

Brabletz, S., Schuhwerk, H., Brabletz, T., & Stemmler, M. P. (2021). Dynamic EMT: a multi-tool for tumor progression. The EMBO journal, 40(18), e108647. https://doi.org/10.15252/embj.2021108647 

Busenhart, P., Montalban-Arques, A., Katkeviciute, E., Morsy, Y., Van Passen, C., Hering, L., Atrott, K., Lang, S., Garzon, J., Naschberger, E., Hartmann, A., Rogler, G., Stürzl, M., Spalinger, M. R., & Scharl, M. (2022). Inhibition of integrin αvβ6 sparks T-cell antitumor response and enhances immune checkpoint blockade therapy in colorectal cancer. Journal for immunotherapy of cancer, 10(2), e003465. https://doi.org/10.1136/jitc-2021-003465

Carta MG, Toegel L, Hoelsken A, Schubart C, Sticht H, Stoehr R, Spoerl S, Meidenbauer N, Hartmann A, Magni P, Haller F, Ferrazzi F. medRxiv 2024.10.10.24315072; doi: https://doi.org/10.1101/2024.10.10.24315072

Clausen BE, Amon L, Backer RA, Berod L, Bopp T, Brand A, Burgdorf S, Chen L, Da M, Distler U, Dress RJ, Dudziak D, Dutertre CA, Eich C, Gabele A, Geiger M, Ginhoux F, Giusiano L, Godoy GJ, Hamouda AEI, Hatscher L, Heger L, Heidkamp GF, Hernandez LC, Jacobi L, Kaszubowski T, Kong WT, Lehmann CHK, Lopez-Lopez T, Mahnke K, Nitsche D, Renkawitz J, Reza RA, Saez PJ, Schlautmann L, Schmitt MT, Seichter A, Sielaff M, Sparwasser T, Stoitzner P, Tchitashvili G, Tenzer S, Tochoedo NR, Vurnek D, Zink F, Hieronymus T. 2022. Guidelines for mouse and human DC functional assays. Eur J Immunol n/a. https://doi.org/10.1002/eji.202249925

Delacher M.*, Schmidleithner L.*, Simon M.*, Stüve P.*, …, Beckhove P., Hehlgans T., Junger H., Geissler E.K., Prantl L., Werner J.M., Schmidl C., Brors B., Imbusch C.D., and Feuerer M. (2024). The effector program of human CD8 T cells supports tissue remodeling. J Exp Med 221 (2): e20230488. doi: 10.1084/jem.20230488 *equal contribution

Dorner H, Stolzer I, Mattner J, Kaminski S, Leistl S, Edrich LM, Schwendner R, Hobauer J, Sebald A, Leikam S, Acera MG, Düll M, Lang R, Seidel G, Seitz T, Hellerbrand C, Fuhrmann G, Distler U, Tenzer S, Eichhorn P, Vieth M, Schramm C, Arnold P, Becker C, Weidinger C, Siegmund B, Atreya R, Leppkes M, Naschberger E, Sampaziotis F, Dietrich P, Rauh M, Wirtz S, Kremer AE, Neurath MF, Günther C. Gut Pathobiont-Derived Outer Membrane Vesicles Drive Liver Inflammation and Fibrosis in PSC-IBD.Gastroenterology. 2024 Jul 9:S0016-5085(24)05203-X. doi: 10.1053/j.gastro.2024.06.032.

Elsner F, Hoffmann M, Fahrioglu-Yamaci R, Czyz Z, Feliciello G, Mederer T, Polzer B, Treitschke S, Rümmele P, Weber F, Wiesinger H, Robold T, Sziklavari Z, Sienel W, Hofmann HS, Klein CA. Disseminated cancer cells detected by immunocytology in lymph nodes of NSCLC patients are highly prognostic and undergo parallel molecular evolution. J Pathol. 2022 Nov;258(3):250-263. doi: 10.1002/path.5996. Epub 2022 Sep 23. PMID: 36148685

Faas M, Ipseiz N, Ackermann J, Culemann S, Grüneboom A, Schröder F, Rothe T, Scholtysek C, Eberhardt M, Böttcher M, Kirchner P, Stoll C, Ekici A, Fuchs M, Kunz M, Weigmann B, Wirtz S, Lang R, Hofmann J, Vera J, Voehringer D, Michelucci A, Mougiakakos D, Uderhardt S, Schett G, and Krönke G (2021). IL-33-induced metabolic reprogramming controls the differentiation of alternativ.ely activated macrophages and the resolution of inflammation. Immunity 54: 2531-2546.e2535. doi: 10.1016/j.immuni.2021.09.010

Fang Q, Stehr AM, Naschberger E, Knopf J, Herrmann M and Stürzl M (2022) No NETs no TIME: Crosstalk between neutrophil extracellular traps and the tumor immune microenvironment. Front. Immunol. 13:1075260. doi: 10.3389/fimmu.2022.1075260

Fuchs, K, Armstark, I, van Roey, R, Hajjaj, Y, D’Avanzo, E, Liguori, R, Ferrazzi, F, Ackermann, J, Amon, L, Alfredo, M, Faas, M, Hübner, J, Hoffmann, M H, Krönke, G, Becker, C, Dudziak, D, Nimmerjahn, F, Brabletz, S, Stemmler, M P, Brabletz, T*, Schuhwerk, H*. (2024). Macrophages foster adaptive anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction. Pre-print bioRxiv: https://doi.org/10.1101/2024.02.26.582102 , *shared senior author.

Fritz, V., Malek, L., Gaza, A., Wormser, L., Appel, M., Kremer, A. E., Thasler, W. E., Siebler, J., Neurath, M. F., Hellerbrand, C., Bosserhoff, A. K., & Dietrich, P. (2021). Combined De-Repression of Chemoresistance Associated Mitogen-Activated Protein Kinase 14 and Activating Transcription Factor 2 by Loss of microRNA-622 in Hepatocellular Carcinoma. Cancers, 13(5), 1183. https://doi.org/10.3390/cancers13051183  

Gaculenko, A., Gregoric, G., Popp, V., Seyler, L., Ringer, M., Kachler, K., Wu, Z., Kisel, W., Hofbauer, C., Hofbauer, L. C., Uder, M., Schett, G., Bäuerle, T., & Bozec, A. (2021). Systemic PPARγ Antagonism Reduces Metastatic Tumor Progression in Adipocyte-Rich Bone in Excess Weight Male Rodents. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 36(12), 2440–2452. https://doi.org/10.1002/jbmr.4422

Gamez-Belmonte, R., Mahapatro, M., Erkert, L., Gonzalez-Acera, M., Naschberger, E., Yu, Y., Tena-Garitaonaindia, M., Patankar, J. V., Wagner, Y., Podstawa, E., Schödel, L., Bubeck, M., Neurath, M. F., Stürzl, M., & Becker, C. (2022). Epithelial presenilin-1 drives colorectal tumour growth by controlling EGFR-COX2 signalling. Gut, gutjnl-2022-327323. Advance online publication. https://doi.org/10.1136/gutjnl-2022-327323

Gaza, A., Fritz, V., Malek, L., Wormser, L., Treiber, N., Danner, J., Kremer, A. E., Thasler, W. E., Siebler, J., Meister, G., Neurath, M. F., Hellerbrand, C., Bosserhoff, A. K., & Dietrich, P. (2021). Identification of novel targets of miR-622 in hepatocellular carcinoma reveals common regulation of cooperating genes and outlines the oncogenic role of zinc finger CCHC-type containing 11. Neoplasia (New York, N.Y.), 23(5), 502–514. https://doi.org/10.1016/j.neo.2021.04.001 

Georg, P., Grasedyck, L., Klever, M., Schill, R., Spang, R., Wettig T.. Low-rank tensor methods for Markov chains with applications to tumor progression models. J. Math. Biol. 86, 7 (2023). https://doi.org/10.1007/s00285-022-01846-9

Gregoric, G., Gaculenko, A., Nagel, L., Popp, V., Maschauer, S., Prante, O., Saake, M., Schett, G., Uder, M., Ellmann, S., Bozec, A., & Bäuerle, T. (2022). Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT. Cancers, 14(10), 2482. https://doi.org/10.3390/cancers14102482

Günther C, Winner B, Neurath MF, Stappenbeck TS. Organoids in gastrointestinal diseases: from experimental models to clinical translation. Gut. 2022 Sep;71(9):1892-1908. doi: 10.1136/gutjnl-2021-326560

Guetter S, Koenig C, Koerkel-Qu H, Markiewicz A, Scheitler S, Katzer M, Berneburg M, Renner P, Cucuruz B, Guttenberger L, Naimer V, Weidele K, Treitschke S, Werno C, Jaser H, Bargmann T, Braun A, Weber F, Rachel R, Baumann F, Schmidleithner L, Schambeck K, Mohammadi P, Ulmer A, Haferkamp S, Klein C A, and Werner-Klein M. (2024). Metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization.  bioRxiv: 2024.2005.2008.591627. doi: 10.1101/2024.05.08.591627

Heger L, Dudziak D, AmonL, Hatscher L, Kaszubowski T, Lehmann CHK. 2022. Guidelines for DC preparation and flow cytometric analysis of human lymphohematopoietic tissues. Eur J Immunol n/a: e2249917. https://doi.org/10.1002/eji.202249917

Heger L, Hatscher L, Liang C, Lehmann CHK, Amon L, Luhr JJ, Kaszubowski T, Nzirorera R, Schaft N, Dorrie J, Irrgang P, Tenbusch M, Kunz M, Socher E, Autenrieth SE, Purbojo A, Sirbu H, Hartmann A, Alexiou C, Cesnjevar R, Dudziak D. 2023. XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors. Proc Natl Acad Sci U S A 120: e2300343120. https://doi.org/10.1073/pnas.2300343120

Heinen, H., Seyler, L., Popp, V., Hellwig, K., Bozec, A., Uder, M., Ellmann, S., & Bäuerle, T. (2021). Morphological, functional, and molecular assessment of breast cancer bone metastases by experimental ultrasound techniques compared with magnetic resonance imaging and histological analysis. Bone, 144, 115821. https://doi.org/10.1016/j.bone.2020.115821 

Heinlein, Lukas, Benz, Michaela, Kuritcyn, Petr, Bruns, Volker, Hartmann, Arndt, Keil, Felix, Geppert, Carol, Evert, Katja and Wittenberg, Thomas. "Lymph node metastases detection in Whole Slide Images using prototypical patterns and transformer-guided multiple instance learning" Current Directions in Biomedical Engineering, vol. 9, no. 1, 2023, pp. 166-169. https://doi.org/10.1515/cdbme-2023-1042

Hellwig, K., Ellmann, S., Eckstein, M., Wiesmueller, M., Rutzner, S., Semrau, S., Frey, B., Gaipl, U. S., Gostian, A. O., Hartmann, A., Iro, H., Fietkau, R., Uder, M., Hecht, M., & Bäuerle, T. (2021). Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma. Frontiers in oncology, 11, 734872. https://doi.org/10.3389/fonc.2021.734872 

Huang J, Demmler R, Mohamed Abdou M, ..., Naschberger E. EXPRESS: Rapid qPCR-Based Quantitative Immune Cell Phenotyping in Mouse Tissues. Journal of Investigative Medicine. 2023;0(ja). doi:10.1177/10815589231210497

Huebner, K., Erlenbach-Wuensch, K., Prochazka, J., Sheraj, I., Hampel, C., Mrazkova, B., Michalcikova, T., Tureckova, J., Iatsiuk, V., Weissmann, A., Ferrazzi, F., Kunze, P., Nalli, E., Sammer, E., Gehring, A., Cheema, M. M., Eckstein, M., Paap, E. M., Soederberg, A., Fischer, C., … Schneider-Stock, R. (2022). ATF2 loss promotes tumor invasion in colorectal cancer cells via upregulation of cancer driver TROP2. Cellular and molecular life sciences : CMLS, 79(8), 423. https://doi.org/10.1007/s00018-022-04445-5

Hübner, J., & Nimmerjahn, F. (2022). Zooming in on dendritic cells for CD40 agonists. Nature cancer, 3(3), 268–269. https://doi.org/10.1038/s43018-022-00340-x

Huttner M, Simeth J, Liguori R, Ferrazzi F and Spang R. (2024). dabih -- encrypted data storage and sharing platform. arXiv 2401.08333. https://doi.org/10.48550/arxiv.2401.08333

Jacobsen A, Siebler J, Grützmann R, Stürzl M, Naschberger E. Blood Vessel-Targeted Therapy in Colorectal Cancer: Current Strategies and Future Perspectives. Cancers (Basel). 2024 Feb 22;16(5):890. doi: 10.3390/cancers16050890 

Khare P, Chand J, Ptakova A, Liguori R, Ferrazzi F, Bishnoi M, Vlachova V, Zimmermann K. The TRPC5 receptor as pharmacological target for pain and metabolic disease. Pharmacol Ther. 2024 Oct 7:108727. doi: 10.1016/j.pharmthera.2024.108727. Epub ahead of print. PMID: 39384022.

Krug, J., Rodrian, G., Petter, K., Yang, H., Khoziainova, S., Guo, W., Bénard, A., Merkel, S., Gellert, S., Maschauer, S., Spermann, M., Waldner, M., Bailey, P., Pilarsky, C., Liebl, A., Tripal, P., Christoph, J., Naschberger, E., Croner, R., Schellerer, V. S., … Britzen-Laurent, N. (2022). N-glycosylation regulates intrinsic IFN-γ resistance in colorectal cancer: implications for immunotherapy. Gastroenterology, S0016-5085(22)01294-X. Advance online publication. https://doi.org/10.1053/j.gastro.2022.11.018

Lasierra Losada, M., Pauler, M., Vandamme, N., Goossens, S., Berx, G., Leppkes, M., Schuhwerk, H., Brabletz, S., Brabletz, T., & Stemmler, M. P. (2021). Pancreas morphogenesis and homeostasis depends on tightly regulated Zeb1 levels in epithelial cells. Cell death discovery, 7(1), 138. https://doi.org/10.1038/s41420-021-00522-z 

Leone, M., Cazorla-Vázquez, S., Ferrazzi, F., Wiederstein, J. L., Gründl, M., Weinstock, G., Vergarajauregui, S., Eckstein, M., Krüger, M., Gaubatz, S., & Engel, F. B. (2021). IQGAP3, a YAP Target, Is Required for Proper Cell-Cycle Progression and Genome Stability. Molecular cancer research : MCR, 19(10), 1712–1726. https://doi.org/10.1158/1541-7786.MCR-20-0639

Mass, E., Nimmerjahn, F., Kierdorf, K. et al. Tissue-specific macrophages: how they develop and choreograph tissue biology. Nat Rev Immunol 23, 563–579 (2023). https://doi.org/10.1038/s41577-023-00848-y 

Mederer T, Elsner F, Robold T, Großer C, Neu R, Ried M, Bleicher S, Schamberger T, Blochberger I, Hofmann HS, Klein CA. EpCAM-positive disseminated cancer cells in bone marrow impact on survival of early-stage NSCLC patients. Lung Cancer. 2022 May;167:73-77. doi: 10.1016/j.lungcan.2022.02.008. Epub 2022 Feb 24. PMID: 35421717 Free article.
MATERIALS AND METHODS: We prospectively collected BM aspirates from 104 non-metastasized NSCLC patients that underwent potentially curative tumor resection from 2011 to 2016 at the Department of Thoracic Surgery of the University Hospital and Hospital Barmherzige Bruder in Reg …

Menche, C.,  Schuhwerk, H., Armstark, I., Gupta, P., Fuchs, K., van Roey, R., Mosa, M., Hartebrodt, A., Hajjaj, Y., Ezquerra, A. C., Selvaraju, M., Geppert, C., Bärthel, S., Saur, D., Greten, F., Brabletz, S., Blumenthal, D., Weigert, A., Brabletz, T., Farin, H., and Stemmler, M.. ZEB1-mediated fibroblast polarization controls inflammation and sensitivity to immunotherapy in colorectal cancer. EMBO Rep. 2024 Jun 27. doi: 10.1038/s44319-024-00186-7

Menck K, Heinrichs S, Wlochowitz D, Sitte M, Noeding H, Janshoff A, Treiber H, Ruhwedel T, Schatlo B, von der Brelie C, Wiemann S, Pukrop T, Beißbarth T, Binder C, and Bleckmann A. (2021). WNT11/ROR2 signaling is associated with tumor invasion and poor survival in breast cancer. Journal of Experimental & Clinical Cancer Research 40. doi: 10.1186/s13046-021-02187-z

Menck K, Wlochowitz D, Wachter A, Conradi L-C, Wolff A, Scheel A, Korf U, Wiemann S, Schildhaus H-U, Bohnenberger H, Wingender E, Pukrop T, Homayounfar K, Beißbarth T, and Bleckmann A. (2022). High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome. Cancers 14. doi: 10.3390/cancers14092084

Naschberger E, Flierl C, Huang J, Erkert L, Gamez-Belmonte R, Gonzalez-Acera M, Bober M, Mehnert M, Becker C, Schellerer VS, Britzen-Laurent N and Stürzl M (2023), Analysis of the interferon-γ-induced secretome of intestinal endothelial cells: putative impact on epithelial barrier dysfunction in IBD. Front. Cell Dev. Biol. 11:1213383. doi: 10.3389/fcell.2023.1213383

Naschberger E, Fuchs M, Dickel N, Kunz M, Popp B, Anchang CG, Demmler R, Lyu Y, Uebe S, Ekici AB, Geppert CI, Hartmann A, Flierl C, Petter K, Gass T, Völkl S, Scharl M, Ramming A, Günther C, Merkel S, Schellerer VS, Stürzl M. Tumor microenvironment-dependent epigenetic imprinting in the vasculature predicts colon cancer outcome. Cancer Commun. http://doi.org/10.1002/cac2.12489

Nimmerjahn, F., & Ravetch, J. V. (2021). Four keys to unlock IgG. The Journal of experimental medicine, 218(3), e20201753. https://doi.org/10.1084/jem.20201753

Nimmerjahn, F., Vidarsson, G. & Cragg, M.S. Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy. Nat Immunol 24, 1244–1255 (2023). https://doi.org/10.1038/s41590-023-01544-8

Pfahler, S., Georg, P., Schill R., Klever, M., Grasedyck, L., Spang, R., Wettig, T.. Taming numerical imprecision by adapting the KL divergence to negative probabilities, 06 February 2024, 2312.13021 (arxiv.org)

Polisetti, N., Gießl, A., Zenkel, M., Heger, L., Dudziak, D., Naschberger, E., Stich, L., Steinkasserer, A., Kruse, F. E., & Schlötzer-Schrehardt, U. (2021). Melanocytes as emerging key players in niche regulation of limbal epithelial stem cells. The ocular surface, 22, 172–189. https://doi.org/10.1016/j.jtos.2021.08.006

Probst HC, Stoitzner P, Amon L, Backer RA, Brand A, Chen J, Clausen BE, Dieckmann S, Dudziak D, Heger L, Hodapp K, Hornsteiner F, Hovav AH, Jacobi L, Ji X, Kamenjarin N, Lahl K, Lahmar I, Lakus J, Lehmann CHK, Ortner D, Picard M, Roberti MP, Rossnagel L, Saba Y, Schalla C, Schlitzer A, Schraml BU, Schutze K, Seichter A, Sere K, Seretis A, Sopper S, Strandt H, Sykora MM, Theobald H, Tripp CH, Zitvogel L. 2022. Guidelines for DC preparation and flow cytometry analysis of mouse nonlymphoid tissues. Eur J Immunol n/a.  https://doi.org/10.1002/eji.202249819

Reitinger, C., Ipsen-Escobedo, A., Hornung, C., Heger, L., Dudziak, D., Lux, A., & Nimmerjahn, F. (2022). Modulation of urelumab glycosylation separates immune stimulatory activity from organ toxicity. Frontiers in immunology, 13, 970290. https://doi.org/10.3389/fimmu.2022.970290

Ruh, M., Stemmler, M. P., Frisch, I., Fuchs, K., van Roey, R., Kleemann, J., Roas, M., Schuhwerk, H., Eccles, R. L., Agaimy, A., Baumhoer, D., Berx, G., Müller, F., Brabletz, T., & Brabletz, S. (2021). The EMT transcription factor ZEB1 blocks osteoblastic differentiation in bone development and osteosarcoma. The Journal of pathology, 254(2), 199–211. https://doi.org/10.1002/path.5659

Rupp, K., Lösch, A., Hu, Y., Nie, C., Schill, R., Klever, M., Pfahler, S., Grasedyck, L., Wettig, T., Beerenwinkel, N., Spang, R.. (2024). Modeling metastatic progression from cross-sectional cancer genomics data. doi: 10.1101/2024.01.30.577989 

Rupp, K., Schill, R., Süskind, J., Georg, P., Klever, M., Lösch, A., Grasedyck, L., Wettig, T., Spang, R.. (2024) Differentiated uniformization: a new method for inferring Markov chains on combinatorial state spaces including stochastic epidemic models. Comput Stat (2024). https://doi.org/10.1007/s00180-024-01454-9

Saha A, Gavert N, Brabletz T, Ben-Ze'ev A (2022). Downregulation of the Tumor Suppressor TFF1 Is Required during Induction of Colon Cancer Progression by L1. Cancers (Basel), 14(18):4478. doi: 10.3390/cancers14184478

Schill, R., Klever, M., Lösch, A., Hu, Y. L., Vocht, S., Rupp, K., Grasedyck, L., Spang, R., Beerenwinkel, N.. Overcoming Observation Bias for Cancer Progression Modeling. bioRxiv 2023.12.03.569824; https://doi.org/10.1101/2023.12.03.569824

Schill, R., Klever, M., Rupp, K., Hu, Y.L., Lösch, A., Georg, P., Pfahler, S., Vocht, S., Hansch, S., Wettig, T., Grasedyck, L., Spang, R. (2024). Reconstructing Disease Histories in Huge Discrete State Spaces. Künstl Intell (2024). https://doi.org/10.1007/s13218-023-00822-9

Schlieben LD#, Carta MG#, Moskalev EA, Stöhr R, Metzler M, Besendörfer M, Meidenbauer N, Semrau S, Janka R, Grützmann R, Wiemann S, Hartmann A, Agaimy A, Haller F, Ferrazzi F. Machine Learning-Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing. J Mol Diagn. 2024 May;26(5):387-398. doi: 10.1016/j.jmoldx.2024.02.002

Schmidleithner L, and Feuerer M. (2022). Tfh cells induce intratumoral tertiary lymphoid structures. Trends Immunol 43: 274-276. doi: 10.1016/j.it.2022.02.010

Schmidleithner L., Stüve P., and Feuerer M. (2024). FOXP3 snatches transcription factors depending on the context. J Exp Med 221 (9): e20240940. doi: 10.1084/jem.20240940

Schott, M., Kappelmann-Fenzl, M., Fischer, S., Fernandez-Barrena, M. G., Pineda-Lucena, A., Ávila, M. A., Kuphal, S., & Bosserhoff, A. K. (2022). Impact of CYLD on chromatin structure and histone methylation in malignant melanoma. International journal of molecular medicine, 49(5), 66. https://doi.org/10.3892/ijmm.2022.5122

Schuhwerk, H., Brabletz T.. Mutual regulation of TGFβ-induced oncogenic EMT, cell cycle progression and the DDR. Semin Cancer Biol. 2023 Dec;97:86-103. doi: 10.1016/j.semcancer.2023.11.009

Schuhwerk, H., Kleemann, J., Gupta, P., van Roey, R., Armstark, I., Kreileder, M., Feldker, N., Ramesh, V., Hajjaj, Y., Fuchs, K., Mahapatro, M., Hribersek, M., Volante, M., Groenewoud, A., Engel, F. B., Ceppi, P., Eckstein, M., Hartmann, A., Müller, F., Kroll, T., … Brabletz, T. (2022). The EMT transcription factor ZEB1 governs a fitness-promoting but vulnerable DNA replication stress response. Cell reports, 41(11), 111819. https://doi.org/10.1016/j.celrep.2022.111819

Schwab, A., Rao, Z., Zhang, J., Gollowitzer, A., Siebenkäs, K., Bindel, N., D’Avanzo, E., van Roey, R., Hajjaj, Y., Özel, E., Armstark, I., Bereuter, L., Su, F., Grander, J., Bonyadi Rad, E., Groenewoud, A., Engel, F. B., Bell, G. W., Henry, W. S., Friedmann Angeli, J. P.,, Stemmler, M. P., Brabletz, S., Koeberle, A., Brabletz, T.. Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Nat Cell Biol (2024). https://doi.org/10.1038/s41556-024-01464-1

Seitz, T., Hackl, C., Freese, K., Dietrich, P., Mahli, A., Thasler, R. M., Thasler, W. E., Lang, S. A., Bosserhoff, A. K., & Hellerbrand, C. (2021). Xanthohumol, a Prenylated Chalcone Derived from Hops, Inhibits Growth and Metastasis of Melanoma Cells. Cancers, 13(3), 511. https://doi.org/10.3390/cancers13030511

Seitz, T., John, N., Sommer, J., Dietrich, P., Thasler, W. E., Hartmann, A., Evert, K., Lang, S. A., Bosserhoff, A., & Hellerbrand, C. (2022). Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche. International journal of molecular sciences, 23(19), 11524. https://doi.org/10.3390/ijms231911524

Simon M.*, Stüve P.*, Schmidleithner L.*, Bittner S., Beumer N., Strieder N., Schmidl C., Pant A., Gebhard C., Eigenberger A., Rehli M., Prantl L, Hehlgans T., Brors B, Imbusch C.D., Delacher M. and Feuerer M. (2024). Single cell chromatin accessibility and transposable element landscapes reveal shared features of tissue-residing immune cells. Immunity, in press *equal contribution

Singh J, Boettcher M, Dölling M, Heuer A, Hohberger B, Leppkes M, Naschberger E, Schapher M, Schauer C, Schoen J, Stürzl M, Vitkov L, Wang H, Zlatar L, Schett GA, Pisetsky DS, Liu ML, Herrmann M, Knopf J. Moonlighting chromatin: when DNA escapes nuclear control. Cell Death Differ. 2023 Apr;30(4):861-875. doi: 10.1038/s41418-023-01124-1

Singh, J., Herrmann, I., Mahajan, A., Schauer, C., Shan, X., Hartmann, A., Rieker, R. J., Evert, K., Falkeis, C., Naschberger, E., von Stillfried, S., Boor, P., Muñoz, L. E., Schett, G., Herrmann, M., & Knopf, J. (2022). A Pleomorphic Puzzle: Heterogeneous Pulmonary Vascular Occlusions in Patients with COVID-19. International journal of molecular sciences, 23(23), 15126. https://doi.org/10.3390/ijms232315126

Staebler, S., Rottensteiner-Brandl, U., El Ahmad, Z., Kappelmann-Fenzl, M., Arkudas, A., Kengelbach-Weigand, A., Bosserhoff, A.-K., Schmidt, S.K. (2024). Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma. Cell Death Dis 15, 351 (2024). https://doi.org/10.1038/s41419-024-06733-3

Stehr, A. M., Wang, G., Demmler, R., Stemmler, M. P., Krug, J., Tripal, P., Schmid, B., Geppert, C. I., Hartmann, A., Muñoz, L. E., Schoen, J., Völkl, S., Merkel, S., Becker, C., Schett, G., Grützmann, R., Naschberger, E., Herrmann, M., & Stürzl, M. (2022). Neutrophil extracellular traps drive epithelial-mesenchymal transition of human colon cancer. The Journal of pathology, 256(4), 455–467. https://doi.org/10.1002/path.5860

Stojanović Gužvić, N., Lüke, F., Treitschke, S., Coluccio, A., Hoffmann, M., Feliciello, G., Varadarajan, A.R., Lu, X., Weidele, K., Botteron, C., Materna–Reichelt, S., Keil, F., Evert, K., Weber, F., Schamberger, T., Althammer, M., Grosse, J., Hellwig, D., Schulz, C., Seitz, S., Ugocsai, P., Schlenska-Lange, A., Mayr, R., Kaiser, U., Dietmaier, W., Polzer, B., Warfsmann, J., Honarnejad, K., Pukrop, T., Heudobler, D., Klein, C.A. and Werno, C. (2024), Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients. Mol Oncol. https://doi.org/10.1002/1878-0261.13741

Stolzer I, Schickedanz L, Chiriac MT, López-Posadas R, Grassl GA, Mattner J, Wirtz S, Winner B, Neurath MF, Günther C. STAT1 coordinates intestinal epithelial cell death during gastrointestinal infection upstream of Caspase-8. Mucosal Immunol. 2022 Jan;15(1):130-142. doi: 10.1038/s41385-021-00450-2

Stürzl, M., Kunz, M., Krug, S. M., & Naschberger, E. (2021). Angiocrine Regulation of Epithelial Barrier Integrity in Inflammatory Bowel Disease. Frontiers in medicine, 8, 643607. https://doi.org/10.3389/fmed.2021.643607

Tao, L., Raz, O., Marx, Z., Ghosh, M. S., Huber, S., Greindl-Junghans, J., Biezuner, T., Amir, S., Milo, L., Adar, R., Levy, R., Onn, A., Chapal-Ilani, N., Berman, V., Arie, A. B., Rom, G., Oron, B., Halaban, R., Czyz Z. T., Werner-Klein, M., Klein, C. A. and Shapiro, E. Retrospective cell lineage reconstruction in humans by using short tandem repeats. Cell Reports Methods, Volume 1 (2021), DOI: 10.1016/j.crmeth.2021.100054

Thoma OM, Naschberger E, Kubánková M, Larafa I, Kramer V, Menchicchi B, Merkel S, Britzen-Laurent N, Jefremow A, Grützmann R, Koop K, Neufert C, Atreya R, Guck J, Stürzl M, Neurath MF, Waldner MJ. p21 Prevents the Exhaustion of CD4⁺ T Cells Within the Antitumor Immune Response Against Colorectal Cancer. Gastroenterology. 2024 Feb;166(2):284-297.e11. doi: 10.1053/j.gastro.2023.09.017

Treitschke S, Weidele K, Varadarajan AR, Feliciello G, Warfsmann J, Vorbeck S, Polzer B, Botteron C, Hoffmann M, Dechand V, Mederer T, Weber F, Werner-Klein M, Robold T, Hofmann HS, Werno C, Klein CA. Ex vivo expansion of lung cancer-derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression. Int J Cancer. 2023 Aug 9. doi: 10.1002/ijc.34658. Online ahead of print. PMID: 37555668

van Roey, R., Brabletz, T., Stemmler, M. P., & Armstark, I. (2021). Deregulation of Transcription Factor Networks Driving Cell Plasticity and Metastasis in Pancreatic Cancer. Frontiers in cell and developmental biology, 9, 753456. https://doi.org/10.3389/fcell.2021.753456

Vorsatz, C., Friedrich, N., Nimmerjahn, F., & Biburger, M. (2021). There Is Strength in Numbers: Quantitation of Fc Gamma Receptors on Murine Tissue-Resident Macrophages. International journal of molecular sciences, 22(22), 12172. https://doi.org/10.3390/ijms222212172

Wang, H.; Stehr, A.M.; Singh, J.; Zlatar, L.; Hartmann, A.; Evert, K.; Naschberger, E.; von Stillfried, S.; Boor, P.; Muñoz, L.E.; et al. Anti-DNA-IgM Favors the Detection of NET-Associated Extracellular DNA. Int. J. Mol. Sci. 2023, 24, 4101. https://doi.org/ 10.3390/ijms24044101

Weber S, Sitte S, Voegele AL, Sologub L, Wilfer A, Rath T, Nägel A, Zundler S, Franchi L, Opipari AW, Sonnewald S, Reid S, Hartmann A, Eichhorn P, Handtrack C, Weber K, Grützmann R, Neufert C, Schellerer VS, Naschberger E, Ekici AB, Büttner C, Neurath MF, Atreya R. NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases. J Crohns Colitis. 2024 Mar 1;18(3):446-461, doi: 10.1177/10815589231210497

Werner, A., & Nimmerjahn, F. (2022). HINGEneering IgG for enhanced immune activation. Science immunology, 7(73), eabq4797. https://doi.org/10.1126/sciimmunol.abq4797

Wittner, L.; Wagener, L.; Wiese, J.J.; Stolzer, I.; Krug, S.M.; Naschberger, E.; Jackstadt, R.; Beyaert, R.; Atreya, R.; Kühl, A.A.; Sturm, G.; Gonzalez-Acera, M.; Patankar, J.V.; Becker, C.; Siegmund, B.;, Trajanoski, Z.; Winner, B.; Neurath, M.F.; Schumann, M.; Günther, C.. Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing. Int. J. Mol. Sci. 2023, 24, 7402. https://doi.org/10.3390/ ijms24087402

Yong Y, Demmler R, Zhang T, Zhou Y, Zohud BA, Schmidt B, Geppert CI, Merkel S, Schellerer VS, Naschberger E*, Stürzl M*. AMIGO2 characterizes cancer-associated fibroblasts in metastatic colon cancer and induces the release of paracrinely active tumourigenic secretomes. J Pathol, in revision.

Yun, D., Yang, Z., Zhang, S., Yang, H., Liu, D., Grützmann, R., Pilarsky, C., & Britzen-Laurent, N. (2022). An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer. Frontiers in cell and developmental biology, 10, 975684. https://doi.org/10.3389/fcell.2022.975684

Zhu L, Tang Y, Li XY, Kerk SA, Lyssiotis CA, Feng W, Sun X, Hespe GE, Wang Z, Stemmler MP, Brabletz S, Brabletz T, Keller ET, Ma J, Cho JS, Yang J, Weiss SJ (2023). A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling.
The EMBO journal,42(7), e111148. doi: 10.15252/embj.2022111148 

Zundler, S., Günther, C., Kremer, A.E., Zaiss, M.M., Rothhammer, V., Neurath, M.F..(2023) Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation. Nat Rev Gastroenterol Hepatol 20, 50–64 (2023). https://doi.org/10.1038/s41575-022-00663-1